Why the study?
Does cardiac procedure/surgery improve health-related quality of life measured by EQ-5D in patients with cardiovascular diseases in Central and Eastern European countries?
Systematic Review (n=36)
Yes
Does cardiac procedure/surgery improve health-related quality of life measured by EQ-5D in patients with cardiovascular diseases in Central and Eastern European countries?
The use of the EQ-5D instrument to measure health-related quality of life in cardiovascular diseases has increased in Central and Eastern European countries, demonstrating measurable improvements in scores following cardiac procedures.
Answers are grounded in this paper and cite their sources.
EQ-5D gains support procedural value in CEE practice; extends global evidence to this region.
BACKGROUND: The measurement of health-related quality of life (HRQoL) by validated generic instruments, such as EQ-5D, has become an increasingly important tool for the assessment of health care in a wide range of diagnoses. AIM: We aimed to systematically review EQ-5D literature on cardiovascular diseases in eight Central and Eastern European (CEE) countries. METHODS: A structured literature search was conducted in MEDLINE, EMBASE, Web of Science, CINAHL, PsycINFO, Cochrane Library, and the EuroQol website up to November 2016. Original cardiovascular-related studies that reported EQ-5D results were included. RESULTS: Of the 36 papers, 17 reported EQ-5D index scores. Most studies were performed in Poland (n = 24, 67%). The most common diagnosis regarding the number of publications and population size was ischaemic heart disease (n = 13, N = 6394), followed by atrial fibrillation (n = 4, N = 1052). The average EQ-5D index scores ranged from 0.61 to 0.88 and from 0.66 to 0.95 for patients before and after cardiac procedure/surgery, respectively (including angioplasty, coronary artery bypass grafting, ablation, surgical correction of septal defects, transcatheter aortic valve implantation [TAVI]). In all studies baseline scores were lower than the repeated assessments after the procedure, with the most substantial improvement of 0.24 in high-risk elderly patients after TAVI. Studies which did not assess invasive treatment reported mean EQ-5D index scores ranging from 0.18 to 0.80. CONCLUSIONS: The number of cardiovascular-related studies reporting HRQoL using EQ-5D has consistently increased in CEE countries over the past decade and is outstanding compared with other clinical fields. The EQ-5D index and EQ VAS scores varied based on the disease severity, patient characteristics, and treatment protocol.
No takes yet. Share an insight, caveat, or question.
Batóg et al. (2018) conducted a systematic review in Cardiovascular diseases (n=36). Cardiac procedure/surgery vs. Baseline (before procedure) was evaluated on EQ-5D index scores.
Synapse has enriched 10 related papers. Consider them for comparative context: